Literature DB >> 1684799

Candida zeylanoides: another opportunistic yeast.

D Levenson1, M A Pfaller, M A Smith, R Hollis, T Gerarden, C B Tucci, H D Isenberg.   

Abstract

A patient with a long history of scleroderma and gastrointestinal malabsorption requiring total parenteral nutrition was admitted with Candida zeylanoides fungemia. The yeast responded to therapy, but on two subsequent admissions for episodes of fever the blood cultures yielded the same yeast. The identity of the Candida species was established biochemically by both the API (Analytab) and Vitek system approaches. C. zeylanoides ATCC 20356 and ATCC 7351 served as controls for these analyses and for antifungal susceptibility studies and restriction endonuclease analyses of chromosomal DNA. These investigations indicated that representative isolates of the yeasts from the three episodes were identical and differed in several respects from the ATCC strains, which did not share many of the characteristics bands with the DNA restriction fragment analysis. C. zeylanoides variants capable of tolerating 35 degrees C can complicate the recovery of patients, especially individuals compromised by their underlying disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684799      PMCID: PMC270185          DOI: 10.1128/jcm.29.8.1689-1692.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Naturally occurring cross-links in yeast chromosomal DNA.

Authors:  M A Forte; W L Fangman
Journal:  Cell       Date:  1976-07       Impact factor: 41.582

2.  Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors:  S Scherer; D A Stevens
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

3.  Transient fungemia and Candida arthritis due to Candida zeylanoides.

Authors:  J Bisbe; J Vilardell; M Valls; A Moreno; M Brancos; J Andreu
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe.

Authors:  D R Reagan; M A Pfaller; R J Hollis; R P Wenzel
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  The use of biotyping and DNA fingerprinting in typing Candida albicans from hospitalized patients.

Authors:  M A Pfaller; I Cabezudo; R Hollis; B Huston; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Nov-Dec       Impact factor: 2.803

6.  Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome.

Authors:  S V Komshian; A K Uwaydah; J D Sobel; L R Crane
Journal:  Rev Infect Dis       Date:  1989 May-Jun
  6 in total
  6 in total

1.  Catheter-related candidemia caused by Candida lipolytica in a patient receiving allogeneic bone marrow transplantation.

Authors:  Domenico D'Antonio; Ferdinando Romano; Eugenio Pontieri; Giuseppe Fioritoni; Claudia Caracciolo; Stefano Bianchini; Paola Olioso; Tommaso Staniscia; Roberta Sferra; Stefania Boccia; Antonella Vetuschi; Giovanni Federico; Eugenio Gaudio; Giuseppe Carruba
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 2.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Resolutive Candida utilis fungemia in a nonneutropenic patient.

Authors:  M E Bougnoux; E Gueho; A C Potocka
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

4.  In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis; R N Jones
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

5.  Candida zeylanoides as a new yeast model for lipid metabolism studies: effect of nitrogen sources on fatty acid accumulation.

Authors:  Priscila Dallé da Rosa; Paula Mattanna; Diórgenes Carboni; Lucio Amorim; Neila Richards; Patricia Valente
Journal:  Folia Microbiol (Praha)       Date:  2014-05-31       Impact factor: 2.099

6.  Biocontrol of Penicillium nordicum growth and ochratoxin A production by native yeasts of dry cured ham.

Authors:  Roberta Virgili; Nicoletta Simoncini; Tania Toscani; Marco Camardo Leggieri; Silvia Formenti; Paola Battilani
Journal:  Toxins (Basel)       Date:  2012-02-01       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.